5-year outcomes from PACE B: an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) vs. conventionally fractionated or moderately hypo fractionated external beam radiotherapy for localized prostate cancer
N. van As*, A. Tree, J. Patel, P. Ostler, H. Van Der Voet, D. A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, J. G. Armstrong, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, G. Manning, S. Brown, C. Griffin, E. Hall
Research output: Contribution to journal › Meeting abstract › peer-review
Fingerprint
Dive into the research topics of '5-year outcomes from PACE B: an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) vs. conventionally fractionated or moderately hypo fractionated external beam radiotherapy for localized prostate cancer'. Together they form a unique fingerprint.